Advancing, Influenza

Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

Veröffentlicht: 17.03.2026 um 21:15 Uhr, prnewswire.co.uk

Sino Biological, Inc. China Texas

en | DE0005765507 | ADVANCING | boerse | 68741502 |